The benefits that can be gained with the validation of these parameters may be significant because they offer the potential for a low-cost, non-invasive and easy-to-read test that can be used to help define the patient’s status, prognosis, and response to therapeutic treatment.
← all excerpts
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
1
—
—